Knowledge of and interest in opioid overdose education and naloxone distribution among US veterans on chronic opioids for addiction or pain

References

• Baca, C., & Grant, K. (2007). What heroin users tell us about overdose. Journal of Addictive Diseases, 26, 63–68
   PubMed Web of Science ®Google Scholar
• Barton, E., Colwell, C., Wolfe, T., Fosnocht, D., Gravitz, C., Bryan, T.,… Bailey, J. (2005). Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting. Journal of Emergency Medicine, 29, 265–271
   PubMed Web of Science ®Google Scholar
• Barton, E., Ramos, J., Colwell, C., Benson, J., Baily, J., & Dunn, W. (2002). Intranasal administration of naloxone by paramedics. Prehospital Emergency Care, 6, 54–58
   PubMedGoogle Scholar
• Bennett, A.S., Bell, A., Tomedi, L., Hulsey, E.G., & Kral, A.H. (2011). Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania. Journal of Urban Health, 88, 1020–1030
   PubMed Web of Science ®Google Scholar
• Bohnert, A., Ilgen, M.A., Trafton, J.A., Kerns, R.D., Eisenberg, A., Ganoczy, D., & Blow, F.C. (2014). Trends and regional variation in opioid overdose mortality among Veterans Health Administration patients, fiscal year 2001 to 2009. Clinical Journal of Pain, 30, 605–612
   PubMed Web of Science ®Google Scholar
• Bohnert, A., Valenstein, M., Bair, M.J., Ganoczy, D., McCarthy, J.F., Ilgen, M.A., & Blow, F.C. (2011). Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA, 305, 1315–1321
   PubMed Web of Science ®Google Scholar
• Boyer, E.W. (2012). Management of opioid analgesic overdose. New England Journal of Medicine, 367, 146–155
   PubMed Web of Science ®Google Scholar
• Buajordet, I., Naess, A., Jacobsen, D., & Brørs O. (2004). Adverse events after naloxone tratment of episodes of suspected acute opioid overdose. European Journal of Emergency Medicine, 11, 19–23
   PubMed Web of Science ®Google Scholar
• Bush, K., Kivlahan, D., McDonell, M., Fihn, S., & Bradley, K. (1998). The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Archives of Internal Medicine, 158, 1789–1795
   PubMed Web of Science ®Google Scholar
• Brason, F.W., Roe, C., & Dasgupta, N. (2013). Project Lazarus: An innovative community response to prescription drug overdose. North Carolina Medical Journal, 74, 259–261
   PubMedGoogle Scholar
• Brugal, M.T., Barrio, G., De, L.F.L., Regidor, E., Royuela, L., & Suelves, J.M. (2002). Factors associated with non-fatal heroin overdose: Assessing the effect of frequency and route of heroin administration. Addiction, 97, 319–327
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2011). Vital signs: Overdoses of prescription opioid pain relievers – United States, 1999–2008. Morbidity & Mortality Weekly Report, 60, 1487–1492
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. (2012a). Opioid overdoses in the United States. Journal of Pain & Palliative Care Pharmacotherapy, 26, 44–47
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. (2012b). Community-based opioid overdose prevention programs providing naloxone – United States, 2010. Morbidity & Mortality Weekly Report, 61, 101–105
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. (2013). National Center for Injury Prevention and Control: Data and statistics web-based injury statistics query and reporting system 2005. Retrieved October 20, 2014, from http://www.cdc.gov/injury/wisqars/LeadingCauses.html
   Google Scholar
• Clark, A., Wilder, C., & Winstanley, E. (2014). A systematic review of community opioid overdose prevention and naloxone distribution programs. Journal of Addiction Medicine, 8, 153–163
   Google Scholar
• Clarke, S., Dargan, P., & Jones, A. (2005). Naloxone in opioid poisoning: Walking the tightrope. Emergency Medicine Journal, 22, 612–616
   PubMed Web of Science ®Google Scholar
• Coffin, P.O., Tracy, M., Bucciarelli, A., Ompad, D., Vlahov, D., & Galea, S. (2007). Identifying injection drug users at risk of nonfatal overdose. Academic Emergency Medicine, 14, 616–623
   PubMed Web of Science ®Google Scholar
• Dahan, A., Aarts, L., & Smith, T.W. (2010). Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology, 112, 226–238
   PubMed Web of Science ®Google Scholar
• Darke, S., Ross, J., & Hall, W. (1996). Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose. Addiction, 91, 405–411
   PubMed Web of Science ®Google Scholar
• Davis, C., Webb, D., & Burris, S. (2013). Changing law from barrier to facilitator of opioid overdose prevention. Journal of Law, Medicine & Ethics, 41, 33–36
   PubMed Web of Science ®Google Scholar
• Dietze, P., Jolley, D., Fry, C., & Bammer, G. (2005). Transient changes in behaviour lead to heroin overdose: Results from a case-crossover study of non-fatal overdose. Addiction, 100, 636–642
   PubMed Web of Science ®Google Scholar
• Dunn, K.M., Saunders, K.W., Rutter, C.M., Banta-Green, C.J., Merrill, J.O., & Sullivan, M.D. (2010). Opioid prescriptions for chronic pain and overdose: A cohort study. Annals of Internal Medicine, 152, 85–92. doi:http://dx.doi.org/10.1059/0003-4819-152-2-201001190-00006
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. (2015). Preventing fatal overdoses: A systematic review of the effectiveness of take-home naloxone. EMDDA Papers. Luxembourg: Publications Office of the European Union
   Google Scholar
• Grieco, E.M., & Cassidy, R.C. (2001). Overview of race and Hispanic origin: Census 2000 brief. Retrieved from http://www.census.gov/prod/2001pubs/c2kbr01-1.pdf
   Google Scholar
• Hall, A.J., Logan, J.E., Toblin, R.L., Kaplan, J.A., Kraner, J.C., & Bixler, D. (2008). Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA, 300, 2613–2620. doi:http://dx.doi.org/10.1001/jama.2008.802
   PubMed Web of Science ®Google Scholar
• Kelly, A., Kerr, D., Dietze, P., Patrick, I., Walker, T., & Koutsogiannis, Z. (2005). Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose. The Medical Journal of Australia, 182, 24–27
   PubMed Web of Science ®Google Scholar
• Kerr, D., Kelly, A., Dietze, P., Jolley, D., & Barger, B. (2009). Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction, 104, 2067–2074
   PubMed Web of Science ®Google Scholar
• Lagu, T., Anderson, B., & Stein, M. (2006). Overdoses among friends: Drug users are willing to administer naloxone to others. Journal of Substance Abuse Treatment, 30, 129–133
   PubMed Web of Science ®Google Scholar
• National Center for Veterans Analysis and Statistics. (2013). Selected Veteran’s Health Administration Characteristics: FY2002 to FY2013. Retrieved June 14, 2015, from http://www.va.gov/vetdata/utilization.asp on
   Google Scholar
• National Treatment Agency for Substance Misuse. (2011). The NTA overdose and naloxone training programme for families and carers. August 2011
   Google Scholar
• Paulozzi, L.J., Budnitz, D.S., & Xi, Y. (2006). Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiology & Drug Safety, 15, 618–627
   PubMed Web of Science ®Google Scholar
• Seal, K., Kral, A., Gee, L., Moore, L., Bluthenthal, R., Lorvick, J., & Edlin, B. (2001). Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area. American Journal of Public Health, 91, 1842–1846
   PubMed Web of Science ®Google Scholar
• Seal, K., Kral, A., Singleton-Banks, S., Hammond, J., Lorvick, J., Ciccarone, D., & Edlin, B. (2003). Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: A survey of street-recruited injectors in San Francisco Bay Area. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 80, 291–301
   PubMed Web of Science ®Google Scholar
• Sporer, K.A., & Kral A.H. (2007). Presciption naloxone: A novel approach to heroin overdose prevention. Annals of Emergency Medicine, 49, 172–177
   PubMed Web of Science ®Google Scholar
• Stoove, M.A., Dietze, P.M., & Jolley, D. (2009). Overdose deaths following previous non-fatal heroin overdose: Record linkage of ambulance attendance and death registry data. Drug & Alcohol Review, 28, 347–352
   PubMed Web of Science ®Google Scholar
• Strang, J., Manning, V., Mayet, S., Best, D., Titherington, E., Santana, L., … Semmler, C. (2008). Overdose Training and Take-home naloxone for opiate users: Prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction, 103, 1648 1657
   Google Scholar
• Strang, J., Powis, B., Best, D., Vingoe, L., Griffiths, P., Taylor, C., & Gossop, M. (1999). Preventing opiate overdose fatalities with take-home naloxone: Prelaunch study of possible impact and acceptibility. Addiction, 94, 199–204
   PubMed Web of Science ®Google Scholar
• Walley, A.Y., Xuan Z., Hackman, H.H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., … Ozonoff, A. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis. BMJ, 346, f174
   PubMed Web of Science ®Google Scholar
• Weber, J., Tataris, K., Hoffman, J., Aks, S., & Mycyk, M. (2012). Can nebulized naloxone be used safely and effectively by emergency medical services for suspected opioid overdose? Prehospital Emergency Care, 16, 289–292
   PubMed Web of Science ®Google Scholar
• Wilder, C.M., Brason, F.W., Clark, A.K., Galanter, M.D., Walley, A.Y., & Winstanley, E.L. (2014). Development and implementation of an opioid overdose prevention program winthin a preexisting substance use disorderstreatment center. Journal of Addiction Medicine, 8, 164–169
   PubMed Web of Science ®Google Scholar
• Yudko, E., Lozhkina, O., & Fouts, A. (2007). A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. Journal of Substance Abuse Treatment, 32, 189–198
   PubMed Web of Science ®Google Scholar